Clover Health Investments, Corp. (CLOV) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $2.71 (-1.27%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Oct 21, 2025 | Whit Mayo | Leerink Partners | $3.00 | +10.5% |
| Dec 17, 2024 | Matt Hewitt | Craig-Hallum | $6.00 | +121.0% |
| Aug 6, 2024 | Richard Close | Canaccord Genuity | $2.50 | -7.9% |
Top Analysts Covering CLOV
CLOV vs Sector & Market
| Metric | CLOV | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.25 | 2.24 | 2.41 |
| Analyst Count | 4 | 8 | 18 |
| Target Upside | +22.6% | +1150.2% | +14.9% |
| P/E Ratio | -15.96 | 6.88 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2.85B | $2.88B | $2.91B | 2 |
| 2027-03-31 | $827M | $828M | $830M | 1 |
| 2027-06-30 | $840M | $841M | $842M | 1 |
| 2027-09-30 | $841M | $842M | $843M | 1 |
| 2027-12-31 | $810M | $811M | $812M | 1 |
| 2028-03-31 | $897M | $898M | $899M | 1 |
| 2028-06-30 | $904M | $905M | $906M | 1 |
| 2028-09-30 | $891M | $893M | $894M | 1 |
| 2028-12-31 | $850M | $851M | $852M | 1 |
| 2029-12-31 | $4.27B | $4.31B | $4.35B | 1 |
| 2030-12-31 | $4.76B | $4.80B | $4.85B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.04 | $0.04 | $0.04 | 1 |
| 2027-03-31 | $0.09 | $0.09 | $0.09 | 1 |
| 2027-06-30 | $0.06 | $0.06 | $0.06 | 1 |
| 2027-09-30 | $-0.00 | $-0.00 | $-0.00 | 1 |
| 2027-12-31 | $-0.08 | $-0.08 | $-0.08 | 1 |
| 2028-03-31 | $0.12 | $0.12 | $0.12 | 1 |
| 2028-06-30 | $0.08 | $0.08 | $0.08 | 1 |
| 2028-09-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-12-31 | $-0.11 | $-0.11 | $-0.11 | 1 |
| 2029-12-31 | $0.21 | $0.21 | $0.21 | 1 |
| 2030-12-31 | $0.28 | $0.28 | $0.28 | 1 |
Frequently Asked Questions
What is the analyst consensus for CLOV?
The consensus among 4 analysts covering Clover Health Investments, Corp. (CLOV) is Buy with an average price target of $3.00.
What is the highest price target for CLOV?
The highest price target for CLOV is $6.00, set by Matt Hewitt at Craig-Hallum on 2024-12-17.
What is the lowest price target for CLOV?
The lowest price target for CLOV is $2.50, set by Richard Close at Canaccord Genuity on 2024-08-06.
How many analysts cover CLOV?
4 analysts have issued ratings for Clover Health Investments, Corp. in the past 12 months.
Is CLOV a buy or sell right now?
Based on 4 analyst ratings, CLOV has a consensus rating of Buy (2.25/5) with a +22.6% upside to the consensus target of $3.00.
What are the earnings estimates for CLOV?
Analysts estimate CLOV will report EPS of $0.04 for the period ending 2026-12-31, with revenue estimated at $2.88B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.